Found 34 matching trials
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer PHASE1 The primary aim is to evaluate the safety (Phase I components) of administe...
Show More Location
Norris Cotton Cancer Center
Learn More & Join Trial
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Bexarotene in Treating Patients With Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of Alabama Comprehensive Cancer Center
Learn More & Join Trial
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE2 The goal of this clinical research study is to evaluate the effectiveness o...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as gemcitabine and bexarotene, ...
Show More Location
Leeds Cancer Centre at St. James's University Hospital
Learn More & Join Trial
Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) PHASE4 This is a multicenter, randomized, open-label, Phase IV study to assess the...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression EARLY_PHASE1 This study plans to learn more about a drug called bexarotene for the treat...
Show More Location
University of Colorado Cancer Center
Learn More & Join Trial
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer PHASE1 This phase I trial studies the side effects and best dose of bexarotene in ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) PHASE1 This is an investigational study that increases the dosage to determine the...
Show More Location
Multiple Locations
Learn More & Join Trial
Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) PHASE1 The main objective is to determine the safety and tolerability of combinati...
Show More Location
Washington University School of Medicine
Learn More & Join Trial